Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Functional dominance in the central dogma of tumor mitochondrial genetics

Subjects

We have discovered recurrent, somatic mutations in mitochondrial ribosomal RNA genes across all tumor types assessed. In contrast with the established idea that the majority of mitochondrial DNA molecules must be mutated to cause an effect, a low allelic dosage of these mutations disrupted mitochondrial protein translation, altering cancer metabolism and transcription.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Mutations of mitochondrial rRNA are prevalent and relevant in tumors.

References

  1. Stewart, J. B. & Chinnery, P. F. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat. Rev. Genet. 16, 530–542 (2015). A review article presenting the role of heteroplasmy in mitochondrial disease.

    Article  CAS  PubMed  Google Scholar 

  2. Boscenco, S., Cumming, E. M., Kim, M., Lareau, C. & Reznik, E. Single-cell technologies for studying the evolution and function of mitochondrial DNA heteroplasmy in cancer. Annu. Rev. Cancer Biol. 9, 161–180 (2025). A review article that expands on a functional role for somatic mtDNA mutations in cancer.

    Article  Google Scholar 

  3. Gorman, G. S. et al. Mitochondrial diseases. Nat. Rev. Dis. Primers 2, 16080 (2016). A review article that explains the threshold effect in hereditary mitochondrial disease.

    Article  PubMed  Google Scholar 

  4. Fu, Y. et al. Engineering mtDNA deletions by reconstituting end joining in human mitochondria. Cell 188, 2778–2793.e21 (2025). A recent article that highlights the threshold effects observed in engineered models of mtDNA deletion.

    Article  CAS  PubMed  Google Scholar 

  5. Mahmood, M. et al. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma. Nat. Cancer 5, 659–672 (2024). This article demonstrates the functional and therapeutic relevance of coding-region mtDNA mutations in melanoma.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Boscenco, S. et al. Functionally dominant hotspot mutations of mitochondrial ribosomal RNA genes in cancer. Nat. Genet. https://doi.org/10.1038/s41588-025-02374-0 (2025).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Functional dominance in the central dogma of tumor mitochondrial genetics. Nat Genet 57, 2630–2631 (2025). https://doi.org/10.1038/s41588-025-02375-z

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41588-025-02375-z

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer